FIELD: medicine.
SUBSTANCE: invention relates to medicine and can be used in neurology in diagnostics of frontal dysfunction. Registration of EEG is performed, spectral power of delta range with analysis of absolute values of power of the δ1-st rhythm and δ2-nd rhythm in frontopolar leads of both cerebral hemispheres is carried out. Absolute values of spectral power of the δ1-st rhythm and δ2-nd rhythm are determined. If obtained values of power of the δ1-st rhythm are from 182 mcV2 to 222 mcV2, the δ2-nd rhythm - from 42 mcV2 to 72 mcV2, dysfunction of frontal lobes is diagnosed.
EFFECT: method extends arsenal of means for diagnosing dysfunction of frontal lobes in patients with vibration disease.
7 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF ESTIMATING EFFICIENCY OF PERFORMED THERAPY OF COGNITIVE DISORDERS AT REHABILITATION STAGE IN PATIENTS WITH VIBRATION DISEASE | 2011 |
|
RU2457779C1 |
METHOD FOR CORRECTION OF COGNITIVE DYSFUNCTION AND VEGETATIVE-SENSORY POLYNEUROPATHY IN PATIENTS WITH VIBRATION DISEASE | 2011 |
|
RU2461373C1 |
DIAGNOSTIC TECHNIQUE OF COGNITIVE DISORDERS IN THE PATIENTS WITH HEMISPHERIC ISCHEMIC STROKE IN THE ACUTE PERIOD | 2019 |
|
RU2712037C1 |
DIAGNOSTIC TECHNIQUE FOR COGNITIVE DISORDERS ACCOMPANYING VIBRATION DISEASE ASSOCIATED WITH COMBINED EFFECT OF LOCAL AND GENERAL VIBRATION | 2019 |
|
RU2712072C1 |
METHOD OF DIAGNOSING AFFECTIVE DISORDERS IN PATIENTS WITH IHD BY DATA OF ENCEPHALOGRAPHIC EXAMINATION | 2009 |
|
RU2419383C1 |
METHOD FOR DIAGNOSING SEVERITY OF VASCULAR COGNITIVE IMPAIRMENT | 2020 |
|
RU2745282C1 |
METHOD FOR DIAGNOSING CHRONIC CEREBRAL ISCHEMIA AT THE STAGE OF MODERATE COGNITIVE DISORDERS WITH ACCOMPANYING ANXIETY-DEPRESSIVE DISORDERS | 2019 |
|
RU2719667C1 |
METHOD OF EARLY DIAGNOSIS OF COGNITIVE IMPAIRMENTS IN YOUNG AND MIDDLE-AGED PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH MINIMAL NEUROLOGICAL SYMPTOMS | 2021 |
|
RU2790236C1 |
METHOD OF DIAGNOSING COGNITIVE DISORDERS OF VASCULAR ORIGIN IN CHRONIC CEREBRAL ISCHEMIA | 2015 |
|
RU2584651C1 |
PREDICTION METHOD OF THERAPY EFFECTIVENESS IN PATIENTS WITH PAROXYSMAL SCHIZOPHRENIA | 2016 |
|
RU2621266C1 |
Authors
Dates
2012-08-10—Published
2011-06-16—Filed